SWARM Biotactics Raised €13M to Advance Bio-Robotics From Lab to Field

KASSEL, Germany & SAN FRANCISCO--(BUSINESS WIRE)--SWARM Biotactics, developer of bio-robotic systems based on fully controllable living insects for mission-critical operations, has secured €10 million in seed funding, bringing its total raised to €13 million, including a €3 million pre-seed. The round was backed by a consortium of international investors from Europe, the United States, and Australia, including Vertex Ventures US, Possible Ventures, and Capnamic, who was the first investor in the pre-seed round. Several early backers also increased their stakes in the oversubscribed round.

SWARM Biotactics secures €13 M seed funding to scale insect-based bio-robotic swarms, delivering silent ISR and real-time data for defense, security and disaster response in high-risk, denied terrain beyond drone and robot reach.

UNMATCHED ACCESS FOR CRITICAL MISSIONS

SWARM Biotactics is creating a new category of robotics: living, intelligent systems designed for environments where machines can’t go—cluttered, denied, and high-risk terrain. Bio-robotic swarms consist of cockroaches equipped with a custom-built backpack for control, sensing, and secure communication—enabling precise navigation and real-time data collection in the most inaccessible places. SWARM delivers highly scalable bio-robotic systems for defense, security, and disaster response.

“We’re entering a decade where access, autonomy, and resilience define geopolitical advantage,” said Stefan Wilhelm, CEO of SWARM Biotactics. “Conventional systems fail where control is needed most—denied zones, collapsed infrastructure, politically complex terrain.

SWARM is the first company building an entirely new category of robotics: biologically integrated, AI-enabled, and mass-deployable systems for persistent intelligence in places no drone or ground robot can reach. This funding moves us from deep tech to deployment—delivering the infrastructure democracies need to operate more smartly, more safely, and with total tactical awareness.”

FROM DEEP TECH R&D TO OPERATIONAL READINESS

SWARM will use the new funding to transition from advanced research to field deployment. Priorities include:

• Launching operational pilots in Europe and North America with defense, national security, and emergency response agencies.
• Scaling production of proprietary sensor backpacks, neural interfaces, and swarm infrastructure.
• Expanding its R&D centers and its international go-to-market and engineering hub.
• Recruiting top talent in insect neurobiology, embedded AI, field robotics, and dual-use system integration.

“Our mission is to build a scalable, dual-use intelligence platform that adapts to any terrain, threat, or mission,” said Moritz Strube, CTO and co-founder. “This funding round validates the vision—and brings in the right global partners to help us scale.”

ABOUT SWARM BIOTACTICS

Founded in 2024, SWARM Biotactics develops fully controllable bio-robotic systems for defense, national security, disaster response, and industrial inspection. By combining biology with edge AI, swarm intelligence, and secure communications, SWARM delivers real-time data from the world’s most inaccessible places. The company is headquartered in Kassel, Germany, with a U.S. subsidiary in San Francisco, California.